| 000 | 01626 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250511193320.0 | ||
| 264 | 0 | _c19920618 | |
| 008 | 199206s 0 0 eng d | ||
| 022 | _a0001-5792 | ||
| 024 | 7 |
_a10.1159/000204713 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSadamori, N | |
| 245 | 0 | 0 |
_aTherapeutic and prognostic value of modal number of chromosomes at the blastic phase of Philadelphia-chromosome-positive chronic myeloid leukemia: comparison based on the same criteria between Nagasaki University and Roswell Park Memorial Institute. _h[electronic resource] |
| 260 |
_bActa haematologica _c1992 |
||
| 300 |
_a49-53 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBlast Crisis _xgenetics |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChromosome Aberrations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xgenetics |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPloidies |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aUnited States |
| 700 | 1 | _aYao, E | |
| 700 | 1 | _aMine, M | |
| 700 | 1 | _aTokunaga, S | |
| 700 | 1 | _aMatsunaga, M | |
| 700 | 1 | _aNakamura, H | |
| 700 | 1 | _aSasagawa, I | |
| 700 | 1 | _aItoyama, T | |
| 700 | 1 | _aHayashibara, T | |
| 700 | 1 | _aSandberg, A A | |
| 773 | 0 |
_tActa haematologica _gvol. 87 _gno. 1-2 _gp. 49-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1159/000204713 _zAvailable from publisher's website |
| 999 |
_c1592253 _d1592253 |
||